Abiopharma

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nucor Announces Guidance for the Second Quarter of 2026 Earnings

Franklin Covey to Report Third Quarter Fiscal 2026 Results

Methode Electronics Announces Fourth Quarter and Full Year Fiscal 2026 Results Conference Call

Legend Biotech Corporation Announces Proposed Public Offering

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

North Dallas Bank & Trust Co. Declares Regular Dividend

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Other Report or Announcement

Verra Mobility Announces Organizational Changes to Accelerate Transformation and Enhance Customer Focus